Pharmaceutical Strategies Group

Pharmaceutical Strategies Group 的所有者是 Omnicell.

是其中之一......

• Russell 3000;
• TOB Iconic 10,000.

Omnicell 是一家在股票代码 OMCL (US) 下上市的公司。

他们在：

• 医疗设备50%
• 药店50%

查看带有其 6 名主要高管的组织结构图

Pharmaceutical Strategies Group 搜索最多的简介

• Michael Lonergan, President
• Gary Golebiewski, Senior Vice President, Business Development
• Beth Hebert-Silvia, Senior Vice President, Health Plans

高管在Pharmaceutical Strategies Group变化

• Rebekah Gregg 曾任 Chief Product Officer, 现升职为 Chief Operating Officer  (新闻发布的2024五月7号).
• Mike Sackett已作为Senior Vice President of Financial Analytics, Procurement and Consulting Stratey加入公司  (新闻发布的2024五月7号).

高管在Omnicell变化

• Nnamdi NjokuNnamdi Njoku 将于202410月6作为 Chief Operating Officer 加入公司  (新闻发布的2024九月26号).

创建提醒
跟踪 Pharmaceutical Strategies Group 的高管变动

Omnicell 拥有 1,837 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。

Popular M&A news in 药店

• Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
• Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
• Lundbeck has announced the acquisition of Longboard Pharmaceuticals  (公布2024十月17号).

药店 行业的其他推荐联系人

• Sanofi 企业 Julie Van Ongevalle - Executive Vice President and Head of Consumer Healthcare
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board
• Braeburn Pharmaceuticals 企业 Seth Harrison - Chairman and Director

了解更多有关药店行业的信息 >

Pharmaceutical Strategies Group 的最新新闻稿

• Insights | Pharmaceutical Strategies Group
• Insights | Pharmaceutical Strategies Group
• Pharmaceutical Strategies Group | PSG | State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group
• Pharmaceutical Strategies Group | PSG | Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group
• Pharmaceutical Strategies Group | PSG | Amjevita, First Biosimilar of Humira, Launches With Two-Tiered Pricing Strategy
• Pharmaceutical Strategies Group | PSG | NEW PRODUCT LAUNCH: PSG Announces Artemetrx Extend
• Pharmaceutical Strategies Group | PSG | Specialty Trend Rose in 2021, but Biosimilars Are Having Impact
• Pharmaceutical Strategies Group | PSG | PSG Announces New Features Designed to Support Biosimilar Strategy
• Pharmaceutical Strategies Group | PSG | Proprietary State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group
• Pharmaceutical Strategies Group | PSG | Trends in Drug Benefit Design Report released by Pharmaceutical Strategies Group
• View more press releases Close

关于 Pharmaceutical Strategies Group 的社交媒体

• Pharmaceutical Strategies Group 在 维基百科、谷歌新闻 和 雅虎财经
• Pharmaceutical Strategies Group 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Michael Lonergan

致电Pharmaceutical Strategies Group，电话：+1 800...

查看组织结构图

Register to receive your alert

报告错误